your market intelligence analyst
Search Results
176 results
Your search is now limited to «Inflammation» expert search.
LocalTechWire 01/20/2020 12:05
Altis Biosystems and Innovate Biopharmaceuticals are among a handful of companies that have raised millions in funding to kick off the new decade. Read more here.
More from LocalTechWire:
Global Research 01/16/2020 10:28
Despite that obstacle, cannabis has now been shown to have significant therapeutic value for a wide range of medical conditions, including cancer, Alzheimer’s disease, multiple sclerosis, epilepsy, glaucoma, lung disease, anxiety, muscle spasms, hepatitis C, inflammatory bowel disease, and arthritis pain.
More from Global Research:
Updated Date: Thu, 16 Jan 2020 00:00:00 EST.
More from National Library of Medicine - DailyMed Drug Label Updates (NLM):
Alzforum News 01/15/2020 13:35
In Alzheimer’s brain, granulovacuolar bodies in neurons harbor activated necrosomes. They correlate with tau pathology and neuron loss, raising new questions about how neurons die in this disease.
More from Alzforum News:
Many studies show a compelling link between oral health, inflammation and chronic conditions such as Type II diabetes, heart disease, autoimmune disorders and even Alzheimer's.
More from Middle East North Africa Financial Network (MENAFN):
GlobeNewswire 01/15/2020 02:39
TOKYO and BASEL, Switzerland, Jan. 15, 2020 (GLOBE NEWSWIRE) -- Dermavant Sciences, a dermatology-focused subsidiary of Roivant Sciences, announced today that it has entered into a collaboration and license agreement with Japan Tobacco Inc. (JT) for exclusive rights to develop, register and market tapinarof in Japan for the treatment of dermatological diseases and conditions, including psoriasis and atopic dermatitis.
More from GlobeNewswire:
AsiaToday 01/14/2020 11:55
Jan 14, 2020. Crisdesalazine demonstrated significant improvement in cognition function in the primary outcome measure. Crisdesalazine demonstrated significant improvement in dementia in the secondary outcome measures. YONGIN, South Korea--(BUSINESS WIRE)--GNT Pharma has successfully completed a Phase III clinical trial for crisdesalazine, a new drug for treating canine cognitive dysfunction syndrome or Alzheimer’s disease. In the clinical study conducted with 48 companion dogs with severe cognitive dysfunction at 7 veterinary hospitals including Seoul National University Animal Hospital, crisdesalazine-treated group demonstrated outstanding and significant efficacy compared to the placebo group in canine cognitive dysfunction rating scale, th.
Business Wire 01/13/2020 02:00
Inflammasomes are understood to drive many chronic inflammatory conditions, from Parkinson’s and Alzheimer’s to asthma, inflammatory bowel disease, chronic kidney disease, cardiovascular disease, arthritis and NASH.
More from Business Wire:
Fight Aging! 01/12/2020 09:43
Fight Aging! publishes news and commentary relevant to the goal of ending all age-related disease, to be achieved by bringing the mechanisms of aging under the control of modern medicine. This weekly newsletter is sent to thousands of interested subscribers. To subscribe or unsubscribe from the newsletter, please visit: Longevity Industry Consulting Services Reason, the founder of Fight Aging! and Repair Biotechnologies, offers strategic consulting services to investors, entrepreneurs, and others interested in the longevity industry and its complexities. To find out more: Contents Further Evidence for Butyrate Produced by Gut Microbes to be Beneficial Revel Pharmace.
More from Fight Aging!:
FeedNavigator (EU) 01/12/2020 00:12
The manipulation of gut microbiota as a target has been suggested to reduce the risks for a number of diseases such as type 2 diabetes mellitus (T2DM). Conversely, T2DM is associated with complications such as gut and brain disorders. Furthermore, the impact of probiotics and prebiotics to improve T2DM complications are reported. Thus, the present study seeks to investigate the therapeutic and neuropsychological effects of L. plantarum and inulin in diabetic rats. Throughout the investigation, L. plantarum, inulin or their combination (synbiotic) was administered to diabetic rats. in the end, fecal samples were collected to evaluate the gut microbial composition. Then behavioral tests were conducted. Subsequently, the obtainment of the pref.
More from FeedNavigator (EU):
Also, there were significant elevations in E selectin H score (P=0.002), percent of expression (P=0.001) and cellular localization (P< 0.001) as well as dermal inflammatory infiltrates in AD cases than controls.
More from International Journal of COPD:
In a new study published in Nature, Stanford neuroscientist Tony Wyss-Coray, Ph.D., and his colleagues report the startling discovery of virus-obsessed immune cells in autopsied brains of deceased Alzheimer's patients, and in cerebrospinal fluid (which bathes our brains) of living individuals diagnosed with the disease. 01/09/2020 06:12
Turmeric has been used for thousands of years both as a spice and as a staple in Ayurvedic medicine for its powerful medicinal properties, including potent antioxidant and anti-inflammatory effects.
More from
PR Newswire 01/08/2020 16:08
PHOENIX, Jan. 8, 2020 /PRNewswire/ -- True Food Kitchen, the award-winning restaurant brand pioneering health-driven dining, has unveiled its Winter Immunity Bowl as part of its winter menu lineup. The restaurant's seasonal menu focuses on immunity-boosting, functional ingredients and...
More from PR Newswire:
Previous studies have implicated certain cell types within the brain’s microenvironment in the spread of AD pathology, including microglia, which are the major inflammatory cells and respond to pathogenesis by phagocytosing and removing damaged cells.
More from Science Translational Medicine:
Medical Research News 01/08/2020 09:28
Other potentially exciting research regarding ketone supplements is being done in the areas of Alzheimer’s disease/dementia, hunger/appetite, reducing inflammation, and improving exercise performance.
More from Medical Research News:

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors


Diagnostics and Therapeutics


Drugs - Brand Names

Drugs - Generic



Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices



Strategic Scenarios



On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 

  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications